Ovid Therapeutics Inc. SEC filings OVID

Ovid Therapeutics Inc. has 532 filings in SEC EDGAR's recent list, going back to Mar 18, 2015. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026. The company's fiscal year ends on December 31.

Ovid Therapeutics Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report Aug 13, 2026 Aug 11, 2026
8-K Current report
Officer or director change
Jul 8, 2026 Jul 5, 2026
8-K Current report
Shareholder vote results
Jun 11, 2026 Jun 11, 2026
8-K Current report
Officer or director change
Jun 3, 2026 May 29, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report May 12, 2026 May 12, 2026
ARS Annual report to shareholders Apr 27, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 27, 2026 —
DEF 14A Proxy statement Apr 27, 2026 Dec 31, 2025
424B3 Prospectus Apr 27, 2026 —
EFFECT Filing Apr 24, 2026 —
CORRESP Letter to the SEC Apr 23, 2026 —
UPLOAD Letter from the SEC Apr 23, 2026 —
S-3 Shelf registration Apr 21, 2026 —
8-K Current report
Other events
Apr 20, 2026 Apr 17, 2026
S-8 Employee stock plan registration Mar 18, 2026 —
10-K Annual report Mar 18, 2026 Dec 31, 2025
8-K Current report
Material agreement, Results of operations, Unregistered share sale
Mar 18, 2026 Mar 17, 2026
EFFECT Filing Dec 22, 2025 —
424B3 Prospectus Dec 22, 2025 —
CORRESP Letter to the SEC Dec 19, 2025 —
8-K Current report
Other events
Dec 18, 2025 Dec 18, 2025
S-3 Shelf registration Dec 15, 2025 —
8-K Current report
Shareholder vote results
Dec 11, 2025 Dec 11, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations, Officer or director change
Nov 12, 2025 Nov 12, 2025
DEF 14A Proxy statement Nov 7, 2025 Dec 11, 2025
PRE 14A Preliminary proxy statement Oct 28, 2025 Dec 11, 2025
PREM14A Filing Oct 27, 2025 Dec 11, 2025
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Oct 3, 2025 Oct 2, 2025
8-K Current report
Other events
Sep 16, 2025 Sep 11, 2025
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
8-K Current report Aug 13, 2025 Aug 13, 2025
8-K Current report
Shareholder vote results
Jul 10, 2025 Jul 10, 2025
8-K Current report
Other events
Jun 25, 2025 Jun 25, 2025
ARS Annual report to shareholders May 22, 2025 Dec 31, 2024
DEFA14A Additional proxy material May 22, 2025 —
DEF 14A Proxy statement May 22, 2025 Dec 31, 2024
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
8-K Current report May 2, 2025 May 1, 2025
PRE 14A Preliminary proxy statement May 2, 2025 Apr 24, 2025
10-K/A Amended annual report Apr 30, 2025 Dec 31, 2024
10-K Annual report Mar 11, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 11, 2025 Mar 10, 2025
8-K Current report
Officer or director change
Mar 5, 2025 Mar 1, 2025
8-K Current report
Listing notice
Feb 13, 2025 Feb 10, 2025
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report Nov 12, 2024 Nov 12, 2024
8-K Current report
Officer or director change
Sep 11, 2024 Sep 8, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
8-K Current report Aug 13, 2024 Aug 13, 2024
8-K Current report
Officer or director change
Aug 2, 2024 Jul 30, 2024
8-K Current report
Other events
Jul 1, 2024 Jul 1, 2024
8-K Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure
Jun 28, 2024 Jun 27, 2024
8-K Current report
Regulation FD disclosure
Jun 17, 2024 Jun 17, 2024
8-K Current report
Shareholder vote results
Jun 7, 2024 Jun 6, 2024
S-8 Employee stock plan registration May 14, 2024 —
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
ARS Annual report to shareholders Apr 24, 2024 Apr 24, 2024
DEFA14A Additional proxy material Apr 24, 2024 —
DEF 14A Proxy statement Apr 24, 2024 Apr 24, 2024
10-K Annual report Mar 8, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 8, 2024 Mar 8, 2024
8-K Current report
Other events
Dec 6, 2023 Dec 4, 2023
EFFECT Filing Nov 15, 2023 —
424B5 Prospectus supplement Nov 15, 2023 —
CORRESP Letter to the SEC Nov 13, 2023 —
UPLOAD Letter from the SEC Nov 8, 2023 —
S-3 Shelf registration Nov 3, 2023 —
10-Q Quarterly report Nov 3, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 3, 2023 Nov 3, 2023
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Oct 18, 2023 Oct 17, 2023
8-K Current report
Other events
Oct 2, 2023 Oct 2, 2023
10-Q Quarterly report Aug 4, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 4, 2023 Aug 4, 2023
8-K Current report
Shareholder vote results
Jun 9, 2023 Jun 8, 2023
S-8 Employee stock plan registration May 5, 2023 —
10-Q Quarterly report May 5, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 5, 2023 May 5, 2023
8-K Current report
Other events
May 1, 2023 May 1, 2023
8-K Current report
Other events
Apr 27, 2023 Apr 27, 2023
ARS Annual report to shareholders Apr 27, 2023 Dec 31, 2022
DEF 14A Proxy statement Apr 27, 2023 Jun 8, 2023
DEFA14A Additional proxy material Apr 26, 2023 —
10-K Annual report Mar 13, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 13, 2023 Mar 13, 2023
8-K Current report
Regulation FD disclosure
Mar 10, 2023 Mar 10, 2023
10-Q Quarterly report Nov 8, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
10-Q Quarterly report Aug 9, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 9, 2022 Aug 9, 2022
8-K Current report
Shareholder vote results
Jun 10, 2022 Jun 9, 2022
8-K Current report
Other events
May 11, 2022 May 10, 2022
10-Q Quarterly report May 10, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 10, 2022 May 10, 2022
DEFA14A Additional proxy material May 2, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Jun 9, 2022
S-8 POS Filing Mar 16, 2022 —
S-8 Employee stock plan registration Mar 15, 2022 —
10-K Annual report Mar 15, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 15, 2022 Mar 15, 2022
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jan 3, 2022 Dec 30, 2021
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Nov 10, 2021 Nov 10, 2021
8-K Current report
Officer or director change
Oct 7, 2021 Oct 6, 2021
8-K Current report
Regulation FD disclosure
Aug 18, 2021 Aug 18, 2021
8-K Current report
Results of operations
Aug 16, 2021 Aug 16, 2021
10-Q Quarterly report Aug 16, 2021 Jun 30, 2021
8-K/A Amended current report
Officer or director change
Aug 11, 2021 Jul 5, 2021
8-K Current report
Officer or director change
Jul 8, 2021 Jul 5, 2021
8-K Current report
Regulation FD disclosure
Jun 23, 2021 Jun 23, 2021
8-K Current report
Shareholder vote results
Jun 11, 2021 Jun 11, 2021
8-K Current report
Officer or director change
Jun 4, 2021 Jun 4, 2021
8-K Current report
Regulation FD disclosure
May 18, 2021 May 18, 2021
10-Q Quarterly report May 13, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 13, 2021 May 13, 2021
DEFA14A Additional proxy material Apr 30, 2021 —
DEF 14A Proxy statement Apr 30, 2021 Jun 10, 2021
8-K Current report
Regulation FD disclosure
Apr 19, 2021 Apr 19, 2021
8-K Current report
Other events
Apr 19, 2021 Apr 19, 2021
8-K Current report
Regulation FD disclosure
Apr 9, 2021 Apr 9, 2021
8-K Current report
Agreement ended
Apr 1, 2021 Mar 29, 2021
8-K Current report
Other events
Mar 30, 2021 Mar 30, 2021
CT ORDER Filing Mar 18, 2021 —
S-8 Employee stock plan registration Mar 18, 2021 —
10-K Annual report Mar 15, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 15, 2021 Mar 15, 2021
8-K Current report
Regulation FD disclosure
Mar 3, 2021 Mar 3, 2021
8-K Current report
Material agreement, Agreement ended
Mar 3, 2021 Mar 2, 2021
8-K Current report
Officer or director change
Dec 21, 2020 Dec 17, 2020
8-K Current report
Other events
Dec 1, 2020 Dec 1, 2020
EFFECT Filing Nov 20, 2020 —
424B5 Prospectus supplement Nov 20, 2020 —
CORRESP Letter to the SEC Nov 18, 2020 —
UPLOAD Letter from the SEC Nov 18, 2020 —
S-3 Shelf registration Nov 13, 2020 —
10-Q Quarterly report Nov 13, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 12, 2020 Nov 12, 2020
8-K Current report
Regulation FD disclosure
Oct 22, 2020 Oct 22, 2020
8-K Current report
Other events
Sep 30, 2020 Sep 30, 2020
8-K Current report
Other events
Aug 26, 2020 Aug 25, 2020
424B5 Prospectus supplement Aug 26, 2020 —
8-K Current report
Other events
Aug 25, 2020 Aug 25, 2020
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 10, 2020 Aug 10, 2020
8-K Current report
Material agreement
Jul 13, 2020 Jul 9, 2020
8-K Current report
Other events
Jun 19, 2020 Jun 19, 2020
8-K Current report
Regulation FD disclosure
Jun 17, 2020 Jun 17, 2020
8-K Current report
Shareholder vote results
Jun 5, 2020 Jun 5, 2020
10-Q Quarterly report May 7, 2020 Mar 31, 2020
8-K Current report
Results of operations, Other events
May 7, 2020 May 7, 2020
DEFA14A Additional proxy material Apr 24, 2020 —
DEF 14A Proxy statement Apr 24, 2020 Jun 4, 2020
8-K Current report
Other events
Mar 30, 2020 Mar 30, 2020
8-K Current report
Regulation FD disclosure
Mar 13, 2020 Mar 13, 2020
S-8 Employee stock plan registration Mar 11, 2020 —
10-K Annual report Mar 11, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 11, 2020 Mar 11, 2020
8-K Current report
Regulation FD disclosure
Mar 2, 2020 Mar 2, 2020
8-K Current report
Other events
Jan 7, 2020 Jan 7, 2020
8-K Current report
Officer or director change
Dec 24, 2019 Dec 18, 2019
424B5 Prospectus supplement Nov 12, 2019 —
10-Q Quarterly report Nov 8, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 8, 2019 Nov 8, 2019
8-K Current report
Change in control, Other events
Nov 1, 2019 Nov 1, 2019
424B5 Prospectus supplement Oct 8, 2019 —
424B5 Prospectus supplement Oct 8, 2019 —
8-K Current report
Other events
Oct 8, 2019 Oct 4, 2019
424B5 Prospectus supplement Oct 3, 2019 —
424B5 Prospectus supplement Oct 3, 2019 —
8-K Current report
Bylaw or fiscal year change
Sep 24, 2019 Sep 23, 2019
8-K Current report
Regulation FD disclosure, Other events
Sep 23, 2019 Sep 23, 2019
8-K Current report
Unregistered share sale, Bylaw or fiscal year change, Shareholder vote results
Sep 19, 2019 Sep 16, 2019
8-K Current report
Other events
Sep 12, 2019 Sep 12, 2019
8-K Current report
Other events
Sep 9, 2019 Sep 5, 2019
S-8 Employee stock plan registration Aug 7, 2019 —
10-Q Quarterly report Aug 7, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 7, 2019 Aug 7, 2019
8-K Current report
Other events
Jul 2, 2019 Jul 2, 2019
8-K Current report
Regulation FD disclosure
Jun 27, 2019 Jun 27, 2019
8-K Current report
Other events
Jun 27, 2019 Jun 27, 2019
8-K Current report
Other events
Jun 18, 2019 Jun 18, 2019
8-K/A Amended current report
Material agreement
Jun 17, 2019 May 10, 2019
8-K Current report
Shareholder vote results
Jun 10, 2019 Jun 7, 2019
8-K Current report
Material agreement
May 15, 2019 May 10, 2019
10-Q Quarterly report May 7, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 7, 2019 May 7, 2019
DEFA14A Additional proxy material Apr 24, 2019 —
DEF 14A Proxy statement Apr 24, 2019 Jun 7, 2019
8-K/A Amended current report
Officer or director change, Other events
Mar 28, 2019 Mar 24, 2019
8-K Current report
Officer or director change, Other events
Mar 28, 2019 Mar 24, 2019
8-K Current report
Other events
Mar 21, 2019 Mar 21, 2019
8-K Current report
Regulation FD disclosure
Mar 11, 2019 Mar 11, 2019
10-K Annual report Mar 7, 2019 Dec 31, 2018
8-K Current report
Results of operations
Mar 7, 2019 Mar 7, 2019
8-K Current report
Officer or director change
Mar 1, 2019 Feb 24, 2019
424B5 Prospectus supplement Feb 22, 2019 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
OVID (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1636651

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.